Madrigal Pharmaceuticals Inc (MDGL)
Sales/Maturities of Investments
$190.20M
Quarterly · Period ending: · USD
MDGL Sales/Maturities of Investments
Latest reported$190.20Mperiod ending
Latest reported$190.20Mperiod ending
MDGL Quarterly Sales/Maturities of Investments ($55.83M → $190.20M)
Quarterly Sales/Maturities of Investments
High-resolution chart · PNG
MDGL sales/maturities of investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 190,203,000 | |
| 353,869,000 | |
| 240,146,000 | |
| 275,069,000 | |
| 273,392,000 | |
| 294,690,000 | |
| 302,431,000 | |
| 214,421,000 | |
| 163,824,000 | |
| 182,607,000 | |
| 113,803,000 | |
| 119,391,000 | |
| 88,211,000 | |
| 11,993,000 | |
| 79,201,000 | |
| 79,367,000 | |
| 98,268,000 | |
| 93,545,000 | |
| 70,505,000 | |
| 155,441,000 | |
| 103,026,000 | |
| 60,302,000 | |
| 111,368,000 | |
| 154,073,000 | |
| 114,594,000 | |
| 109,421,000 | |
| 181,857,000 | |
| 169,222,000 | |
| 128,716,000 | |
| 170,387,000 | |
| 114,419,000 | |
| 51,051,000 | |
| 48,763,000 | |
| 20,071,000 | |
| 41,386,000 | |
| -13,089,000 | |
| 8,470,000 | |
| 11,563,000 | |
| 17,484,000 | |
| -32,246,154 | |
| 9,225,000 | |
| 31,600,000 | |
| 35,759,000 | |
| 37,186,000 | |
| 27,248,000 | |
| 37,000,000 | |
| 24,464,000 | |
| 15,250,000 | |
| 25,670,000 | |
| 19,768,000 | |
| 27,900,000 | |
| 18,408,000 | |
| 25,009,000 | |
| 18,950,000 | |
| 10,750,000 | |
| 16,500,000 | |
| 3,695,000 | |
| 9,650,000 | |
| 24,101,000 | |
| 14,302,000 | |
| 11,000,000 | |
| 11,342,000 | |
| 17,250,000 | |
| 0 | |
| 0 | |
| 0 | |
| 16,940,000 | |
| 21,253,000 | |
| 20,004,000 | |
| 2,609,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 1,000,000 | |
| 27,149,000 | |
| 28,734,000 | |
| 55,828,000 |